It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Uncover ways to make extra money without spending and increase your savings. These strategies can help you boost your income effortlessly.
23,653 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Bitcoin climbs toward $65,000 as inflation data softens. This guide breaks down what the move means for crypto invest...
Bitcoin climbs toward new highs as Coinbase faces regulatory headlines. This piece breaks down what it means for mass...
Institutional buyers are flocking to STRC, Strategy’s variable-rate perpetual preferred stock, driving an 11% yield a...
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...
XRP breaks past $1.50 and overtakes BNB in market cap as open interest on Binance surges. The move suggests traders a...
Bitcoin built on recent gains as macro risk appetite improved and liquidity returned, setting the stage for a test of...
A recent SEC filing shows Marshall Investment Management adding a sizable stake to the TCW Flexible Income ETF (FLXR)...
XRP-linked ETFs are drawing persistent institutional inflows even as XRP trades in a tight $1.40-$1.47 range. A fresh...
Texas is not just growing; it's redefining where Americans want to live. This article explores how texas dominates co...
This comprehensive guide explains what frequent intraday trading is, who it suits, and how to manage risk with real-w...
Investors debating IHE vs XBI face a trade-off between stability and growth. This guide breaks down how ishares pharm...